Skip to content
This website uses cookies to help us understand the way visitors use our website. We can't identify you with them and we don't share the data with anyone else. If you click Reject we will set a single cookie to remember your preference. Find out more in our privacy policy.

Navigation breadcrumbs

  1. Home
  2. Latest
  3. UCLPartners shortlisted for two HSJ Partnership awards

UCLPartners shortlisted for two HSJ Partnership awards

12 January 2022
Two projects join the shortlist, with winners due to be announced on 24 March.

UCLPartners is delighted to announce that it has been shortlisted for two awards at the HSJ Partnership Awards 2022, recognising outstanding contributions to healthcare.

UCLPartners has been shortlisted with Barts Health NHS Trust for the ‘Bedside Learning Coordinator Approach to Care Redesign’ in the Most Effective Contribution to Clinical Redesign category, and for ‘Living with Covid Recovery’, with Barts Health NHS Trust and Living With, in the Healthtech Partnership of the Year category.  The winners will be announced on March 24.

Standing out amongst tough competition from hundreds of other exemplary applicants, the Bedside Learning Coordinator and Living With Covid Recovery projects have been selected based on their ambition, visionary spirit and the demonstrable positive impact that the projects have had on patient and staff experiences within the health sector.

For the Bedside Learning Coordinator, UCLPartners and Barts Health worked together at Nightingale Hospital London to develop an innovative role to rapidly improve care delivery during COVID-19. Front-line staff often have the greatest insights about how to improve patient care and staff experience. The ‘Bedside Learning Coordinator’ role was designed to capture staff insights and provide rapid feedback to leadership teams to inform decision-making and communicate changes with staff and support improvements. The impact included improved safety, effectiveness, workplace efficiency, and staff well-being. The model was subsequently implemented by Barts Health during the second wave and spread to other NHS organisations.

Living With Covid Recovery is an innovative digital programme to treat the long-lasting symptoms of COVID-19 infection. Around 60% of hospitalised, and 10% of non-hospitalised survivors of COVID-19 develop long term symptoms, including fatigue, ‘brain fog’, feeling breathless or having low mood and/or anxiety. The Living With rehabilitation tool was developed by an interdisciplinary team to target Long Covid, combining evidence-based methods from physiotherapists, psychologists, dieticians and respiratory physicians to create bespoke treatment plans for each patient. By delivering rehabilitation remotely, the programme helps NHS staff support more patients than would normally be possible, in a timely and cost-effective way. Following successful use across Barts Health NHS Trust, the programme continues to expand and is helping over 2894 patients with their recovery across 30 clinics in 20 NHS trusts.

Despite the demanding circumstances of the past two years, over 190 entries have been received for this year’s HSJ Partnership Awards, with 123 projects making it to the final shortlist.

The judging panel was once again made up of a diverse range of highly influential and respected figures within the healthcare community, including Dr Matt Aiello (National Programmes Lead, Education Reform, Health Education England); Dr Elena Bechberger (National Programme Director – LVHC Programme, NHS England and NHS Improvement); Claire Igoe (Head of Environmental Sustainability – Manchester University FT) and Vinice Thomas (Director of Nursing and Quality, NHS England and NHS Improvement).

View the full list of nominees for the HSJ Partnership Awards 2022.

More information

Living With Covid Recovery is a collaboration between UCL, Barts Health NHS Trust, UCLPartners, NIHR ARC North Thames, NIHR ARC Wessex, University of Southampton, University of Exeter, health-tech remote management start-up Living With, and over 200 patients and public representatives that were consulted.